As of 3:59pm ET
| -1.22 / -6.50%|
Fresenius SE & Co. KGaA engages in the provision of healthcare related products and services. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment provides dialysis products and services. The Fresenius Kabi segment specializes in intravenously administered generic drugs, clinical nutrition, and infusion therapies. The Fresenius Helios segment operates acute and maximum care hospitals as well as post-acute care clinics. The Fresenius Vamed segment manages projects and offers services for hospitals and other healthcare facilities. The Corporate and Other segment comprises the holding activities of the company and the information technology service provider Fresenius Netcare. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.
|Ulf Mark Schneider||Chairman-Management Board|
|Stephan Sturm||Chief Financial Officer|
|Jürgen Götz||Chief Legal, Compliance & Human Resources Officer|
|Rice Powell||Member-Management Board|
|Francesco de Meo||Member-Management Board|